No Data
No Data
Hong Kong stocks unusual | Wuxi Bio (02269) rose more than 6%, leading the CRO concept. The Federal Reserve announced aggressive interest rate cuts, and the prospects for financing and investment in innovative drugs are expected to continue to improve.
CRO concept stocks rose across the board in early trading. As of the time of publication, Wuxi Bio (02269) rose 6.25% to HKD 12.24; Tigermed (03347) rose 5.2% to HKD 27.3; Pharmaron (03759) rose 5.34% to HKD 10.06; and Asymchem Laboratories (06821) rose 4.63% to HKD 44.1.
Shareholders in Hangzhou Tigermed Consulting (SZSE:300347) Are in the Red If They Invested Three Years Ago
Hangzhou Tigermed Consulting Among 3 Chinese Stocks Estimated To Be Undervalued
Tigermed Schedules EGM for Major Corporate Updates
Contract research organizations are generally declining. Wuxi Apptec (02359) fell 9.74%. The uncertainty of the Biosecurity Law Bill weakened investor confidence.
Jinwu Finance News | The concept of contract research organizations is generally trending downward. Wuxi Apptec (02359) fell 9.74%, Frontage (01521) fell 5.36%, Tigermed (03347) fell 4.57%, Wuxi Bio (02269) fell 3.7%, and Pharmaron (03759) fell 3.13%. Citigroup has released a report stating that the U.S. House of Representatives has passed the Biosecurity Bill, but it is currently unknown whether the Senate will adopt the House version of the bill, or consider another version, or even incorporate the Biosecurity Bill into a larger comprehensive bill. Nevertheless, Citigroup believes that
HK stocks fluctuate | CRO concept stocks plummeted in early trading. The U.S. House of Representatives has passed the draft of the Biosecurity Law, and related companies have quickly issued clarification announcements.
CRO concept stocks tumbled in the morning session, as of the time of publication, wuxi apptec (02359) fell by 9.74%, closing at HK$32.45; frontage (01521) fell by 10.71%, closing at HK$0.5; pharmaron (03759) fell by 4.31%, closing at HK$8.87; tigermed (03347) fell by 3.66%, closing at HK$26.35.
No Data
No Data